Retrospective analysis of adjuvant treatment for localized, operable uterine leiomyosarcoma
Abstract Objective Currently, there is no standard adjuvant treatment protocol for localized uterine leiomyosarcoma (uLMS) as clinical trials to address this question have been retrospective, underpowered, or undermined by slow accrual rates. The aim of this study is to determine the benefit of adju...
| Published in: | Cancer Medicine |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-08-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.4665 |
